Ayahuasca, Esketamine and PTSD
ConditionPosttraumatic Stress Disorder (PTSD)
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Sao Paulo
About this trial
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Eligibility criteria
Qualifiers
posttraumatic stress disorder
Disqualifiers
psychiatric and other medical comorbidities
Trial design
Treatments tested in this trial
- Ayahuasca
- Esketamine
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov